Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

1.0K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.0K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

614
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
614
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

657
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
657
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.1K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.4K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.4K
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

1.9K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Empowering Front-Line Decision Making Through Self-Service Analytics in the Electronic Patient Records System at Unity Health Toronto.

Studies in health technology and informatics·2026
Same author

Limitations associated with transcranial direct current stimulation for enhancement: considerations of performance tradeoffs in active-duty Soldiers.

Frontiers in human neuroscience·2024
Same author

Measuring aviator workload using EEG: an individualized approach to workload manipulation.

Frontiers in neuroergonomics·2024
Same author

Longitudinal Changes in the Body Mass Index of British Army Pilots.

Aerospace medicine and human performance·2024
Same author

Retrospective Analysis of Medical Attrition for Pilot Applicants to the British Army Air Corps.

Aerospace medicine and human performance·2024
Same author

Preliminary Evaluation of an Osteopathic Manipulative Treatment to Prevent Motion Sickness.

Aerospace medicine and human performance·2024

Related Experiment Video

Updated: Nov 25, 2025

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

38.9K

Selective Serotonin Reuptake Inhibitor Use Among Army Aviators.

Amanda M Kelley, Kyle Bernhardt, Mark McPherson

    Aerospace Medicine and Human Performance
    |December 18, 2020
    PubMed
    Summary

    Selective serotonin reuptake inhibitors (SSRIs) are used by Army aviators for mental health conditions. This review of 114 cases from 2005-2015 shows SSRI use is manageable with evidence-based policies for aviation safety.

    More Related Videos

    Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
    09:29

    Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

    Published on: January 9, 2015

    15.7K
    Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
    08:20

    Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

    Published on: January 18, 2021

    4.2K

    Related Experiment Videos

    Last Updated: Nov 25, 2025

    The Forced Swim Test as a Model of Depressive-like Behavior
    05:42

    The Forced Swim Test as a Model of Depressive-like Behavior

    Published on: March 2, 2015

    38.9K
    Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
    09:29

    Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

    Published on: January 9, 2015

    15.7K
    Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
    08:20

    Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

    Published on: January 18, 2021

    4.2K

    Area of Science:

    • Aerospace Medicine
    • Psychiatry
    • Epidemiology

    Background:

    • Mental health significantly impacts Army aviator career longevity, readiness, and healthcare utilization.
    • Selective serotonin reuptake inhibitors (SSRIs) are a common pharmacotherapy for mental health disorders.
    • Understanding SSRI use in aviators is crucial for maintaining flight safety and personnel well-being.

    Purpose of the Study:

    • To conduct a descriptive epidemiological review of SSRI use in U.S. Army aviators.
    • To analyze the primary diagnoses and aeromedical dispositions associated with SSRI use.
    • To inform aeromedical decision-making regarding mental health treatment in aviation personnel.

    Main Methods:

    • Archival data from the U.S. Army Aeromedical Electronic Resource Office (AERO) from 2005 to 2015 were utilized.
    • A subset of data pertaining to SSRI use was extracted for analysis.
    • Frequencies of primary diagnoses and aeromedical outcomes were calculated.

    Main Results:

    • 114 unique cases of SSRI use were identified, resulting in 122 aeromedical outcomes.
    • Waiver recommendations (41), suspension recommendations (59), and waiver continuations (22) were documented.
    • Top diagnoses included depressive disorder (32), anxiety state (21), and posttraumatic stress disorder (16).

    Conclusions:

    • SSRI use can be safely integrated into Army aviation with evidence-based policies and careful aeromedical risk assessment.
    • Proactive management and oversight of mental health treatment in aviators are essential for performance and safety.
    • Addressing mental health concerns openly prevents negative impacts on aviator performance and aviation safety.